Progenics Pharmaceuticals Inc. (PGNX) financial statements (2021 and earlier)

Company profile

Business Address ONE WORLD TRADE CENTER
NEW YORK, NY 10007
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments42138911397411966
Cash and cash equivalents42138911397411966
Receivables16445403
Other current assets6324632
Total current assets:64144971488312271
Noncurrent Assets
Operating lease, right-of-use asset13
Property, plant and equipment12445232
Long-term investments and receivables      2
Long-term investments      2
Intangible assets, net (including goodwill)25204344443639
Goodwill181313131388
Intangible assets, net (excluding goodwill)773031312931
Other noncurrent assets6222200
Total noncurrent assets:56254951483944
TOTAL ASSETS:119169146199131161115
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:141113161077
Accounts payable1031011
Accrued liabilities1311101641 
Employee-related liabilities    222
Other undisclosed accounts payable and accrued liabilities    334
Debt852    
Business combination, contingent consideration, liability 7    
Other liabilities   0000
Total current liabilities:222315161077
Noncurrent Liabilities
Long-term debt and lease obligation47394749   
Long-term debt, excluding current maturities32394749   
Operating lease, liability15
Liabilities, other than long-term debt46201620181
Deferred revenue and credits1100 
Deferred income tax liabilities0
Other liabilities 221111
Business combination, contingent consideration, liability4417141917
Other undisclosed noncurrent liabilities 0012111128
Total noncurrent liabilities:51456778312929
Total liabilities:73688394413636
Stockholders' equity
Stockholders' equity attributable to parent47101631059012579
Common stock0000000
Treasury stock, value(3)(3)(3)(3)(3)(3)(3)
Common stock, share subscribed but unissued, subscriptions receivable  (2)    
Additional paid in capital727713610598595590549
Accumulated other comprehensive loss(0)(0)(0)(0)(0) (0)
Accumulated deficit(678)(609)(542)(491)(501)(462)(467)
Stockholders' equity attributable to noncontrolling interest    0  
Total stockholders' equity:47101631059112579
TOTAL LIABILITIES AND EQUITY:119169146199131161115

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues351612699448
Revenue, net12699446
Other operating income     7 
Cost of revenue(4)    (0)(1)
Cost of goods and services sold(3)    (0)(1)
Gross profit:311612699447
Operating expenses(97)(82)(70)(56)(48)(48)(51)
Other undisclosed operating income     81
Operating income (loss):(66)(66)(58)13(39)3(43)
Nonoperating income (expense)(2)(3)(4)(1)000
Investment income, nonoperating    000
Income (loss) from continuing operations before income taxes:(69)(69)(63)13(39)3(43)
Income tax expense (benefit)(0)212(2)010
Net income (loss):(69)(68)(51)11(39)4(43)
Net income attributable to noncontrolling interest   00  
Net income (loss) available to common stockholders, diluted:(69)(68)(51)11(39)4(43)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(69)(68)(51)11(39)4(43)
Other comprehensive income (loss)   (0)(0)00
Other undisclosed comprehensive income (loss) (0)0    
Comprehensive income (loss):(69)(68)(51)11(39)5(43)
Comprehensive income, net of tax, attributable to noncontrolling interest   00  
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)      
Comprehensive income (loss), net of tax, attributable to parent:(69)(68)(51)11(39)5(43)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: